Alignment Healthcare, Inc. (ALHC)
NASDAQHealth CareMedical - Healthcare PlansSnapshot 2026-11-04
$7.56-7.13%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Healthcare PlansSnapshot 2026-11-04
QuarterlyIQ Insights · ALHC
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Health plan membership at the end of the quarter was approximately 301,200, up 31.2% year-over-year Total revenue was $1,358.3 million, up 36.7% year-over-year Adjusted gross profit* was $142.2 milli…
Stated in 2 of 2 supplied quarters. Management reported: “Health plan membership at the end of the quarter was approximately 301,200, up 31.2% year-over-year Total revenue was $1,358.3 million, up 36.7% year-over-year Adjusted gross profit* was $142.2 million, up 11.6% year-over-year, and loss from operations was $3.8 million Adjusted gross profit excludes depreciation and amortization of $8.1 million and selling, general, and administrative expenses of $136.4 million (which includes $16.0 million of equity-based compensation).”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated strong grew net income 53% of the time over the next year (vs 42% for the rest of the cohort, n=10089).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Health plan membership at the end of the quarter was approximately 301,200, up 31.2% year-over-year Total revenue was $1,358.3 million, up 36.7% year-over-year Adjusted gross profit* was $142.2 milli…”
“Health plan membership at the end of the quarter was approximately 294,100, up 31.5% year-over-year Total revenue was $1,335.6 million, up 31.6% year-over-year Adjusted gross profit* was $182.9 milli…”
Health plan membership at the end of the quarter was approximately 301,200, up 31.2% year-over-year Total revenue was $1,358.3 million, up 36.7% year-over-year Adjusted gross profit* was $142.2 milli…
Stated in 2 of 2 supplied quarters. Management reported: “Health plan membership at the end of the quarter was approximately 301,200, up 31.2% year-over-year Total revenue was $1,358.3 million, up 36.7% year-over-year Adjusted gross profit* was $142.2 million, up 11.6% year-over-year, and loss from operations was $3.8 million Adjusted gross profit excludes depreciation and amortization of $8.1 million and selling, general, and administrative expenses of $136.4 million (which includes $16.0 million of equity-based compensation).”
“Health plan membership at the end of the quarter was approximately 301,200, up 31.2% year-over-year Total revenue was $1,358.3 million, up 36.7% year-over-year Adjusted gross profit* was $142.2 milli…”
“Health plan membership at the end of the quarter was approximately 294,100, up 31.5% year-over-year Total revenue was $1,335.6 million, up 31.6% year-over-year Adjusted gross profit* was $182.9 milli…”
The medical benefits ratio result reflects previously expected changes in Part D seasonality and timing of clinical investments, along with higher costs from elevated appeals and disputes and increas…
Stated in 2 of 2 supplied quarters. Management reported: “The medical benefits ratio result reflects previously expected changes in Part D seasonality and timing of clinical investments, along with higher costs from elevated appeals and disputes and increased costs within catastrophic cases and skilled nursing categories Adjusted EBITDA* of $21.8 million represented an adjusted EBITDA margin of 1.6% and declined 32.8% year-over-year, while net loss was $8.1 million, compared to net income of $3.7 million the year prior * Please see “Third Quarter 2026 Non-GAAP Reconciliation Tables” below for more information on the non-GAAP financial measures reported here as supplemental information.”
“The medical benefits ratio result reflects previously expected changes in Part D seasonality and timing of clinical investments, along with higher costs from elevated appeals and disputes and increas…”
“Adjusted gross profit also excludes $1.9 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 86.3%, an improvement of appro…”
Scale the business while pursuing consistent operating performance and profitable growth over the long term.
Over the trailing year it converted 0.53x of net income into operating cash flow.
Not enough signal yet.
Not enough signal to read sensitivity to the broad stock market, the US dollar, real (inflation-adjusted) rates, Fed net liquidity, long-term interest rates (low R² over the window).
14 material management or governance events in the past 24 months, led by legal/regulatory items. Historically, Health Care names rated neutral grew net income 46% of the time over the next year (vs 44% for the rest of the cohort, n=13229).
Not investment advice. As of 2026-11-04.